tradingkey.logo
搜尋

Bone Biologics Corp

BBLG
添加自選
1.420USD
+0.020+1.43%
收盤 07/02, 13:00美東報價延遲15分鐘
2.55M總市值
虧損本益比TTM

關於 Bone Biologics Corp 公司

Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.

Bone Biologics Corp簡介

公司代碼BBLG
公司名稱Bone Biologics Corp
上市日期Nov 27, 2015
CEOFrelick (Jeffrey)
員工數量2
證券類型Ordinary Share
年結日Nov 27
公司地址2 Burlington Woods Dr Ste 100
城市BURLINGTON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編01803-4551
電話17815524452
網址https://www.bonebiologics.com/
公司代碼BBLG
上市日期Nov 27, 2015
CEOFrelick (Jeffrey)

Bone Biologics Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+0.84%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--
Mr. Jody Cain
Mr. Jody Cain
Investor Relation
Investor Relation
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+0.84%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--

常見問題

Bone Biologics Corp的前五大股東是誰?

Bone Biologics Corp的前五大股東如下:Mr. Jeffrey Frelick

有多少機構持有Bone Biologics Corp(BBLG)的股份?

截至2026Q1,共有17家機構持有Bone Biologics Corp的股份,合計持有的股份價值約為58.41K,占公司總股份的3.25% 。與2025Q4相比,機構持股有所增加,增幅為22009.00。